TIDMAMS
RNS Number : 6157J
Advanced Medical Solutions Grp PLC
29 June 2017
29 June 2017
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR and PCA Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS),
the surgical and advanced wound care specialist company, announces
that it was notified on 26 June 2017 that Chris Meredith, who is a
Director and PDMR, following the successful achievement of certain
performance criteria, has exercised 162,069 options from the Long
Term Incentive Plan (LTIP). Mr Meredith subsequently sold 76,604
Ordinary Shares of 5p each on 26 June 2017 at a share price of
301.8015p per Ordinary Share to cover the tax payable on this
exercise.
As a result of these transactions Chris Meredith's beneficial
interest in the Company has increased from 1,384,841 shares to
1,470,306 shares.
Long Term Incentive Plan (LTIP)
Director No. of LTIPs Ordinary Ordinary LTIPs
LTIPs prior exercised Shares shares after
to exercise sold retained exercise
------------------ ------------- ----------- --------- ---------- ----------
Chris Meredith,
Chief Executive
Officer 583,509 162,069 76,604 85,465 421,440
------------------ ------------- ----------- --------- ---------- ----------
Overall Holding
Director Holding Number Number Sale Resultant % of
prior of shares of shares price holding issued
to exercise exercised sold (p) share
capital
----------------- ------------- ----------- ----------- ---------- ---------- ---------
Chris Meredith,
Chief
Executive
Officer 1,384,841 162,069 76,604 301.8015p 1,470,306 0.69%
----------------- ------------- ----------- ----------- ---------- ---------- ---------
The Company further announces that it was notified on 26 June
2017 that Mary Tavener, who is a Director and PDMR, following the
successful achievement of certain performance criteria, has
exercised 162,069 options from the Long Term Incentive Plan (LTIP).
Mrs Tavener subsequently sold 54,519 Ordinary Shares of 5p each on
26 June 2017 at a share price of 301.8015p per Ordinary Share to
cover the tax payable on this exercise.
As a result of these transactions Mary Tavener's beneficial
interest in the Company has increased from 1,890,647 shares to
1,954,191 shares.
Long Term Incentive Plan (LTIP)
Director No. of LTIPs Ordinary Ordinary LTIPs
LTIPs prior exercised Shares shares after
to exercise sold retained exercise
------------------ ------------- ----------- --------- ---------- ----------
Mary Tavener,
Chief Financial
Officer 442,265 114,440 54,519 63,544 327,825
------------------ ------------- ----------- --------- ---------- ----------
Overall Holding
Director Holding Number Number Sale Resultant % of
prior of shares of shares price holding issued
to exercise exercised sold (p) share
capital
--------------- ------------- ----------- ----------- ---------- ---------- ---------
Mary Tavener,
Chief
Financial
Officer 1,890,647 114,440 54,519 301.8015p 1,954,191 0.92%
--------------- ------------- ----------- ----------- ---------- ---------- ---------
The Company further announces that it was notified on 26 June
2017 that Jeff Willis, who is a Senior Manager and PDMR, following
the successful achievement of certain performance criteria, has
exercised 38,450 options from the Long Term Incentive Plan (LTIP).
Following this transaction the beneficial ownership of Jeff Willis
is as follows:
Long Term Incentive Plan (LTIP)
PDMR No. of LTIPs LTIPs exercised Ordinary LTIPs after
prior to shares exercise
exercise retained
------------- ------------- ---------------- ---------- ------------
Jeff Willis 161,044 38,450 38,450 122,594
------------- ------------- ---------------- ---------- ------------
Overall Holding
PDMR Holding Number of Resultant % of issued
prior to shares exercised holding share
exercise capital
------------- ---------- ------------------ ---------- ------------
Jeff Willis 130,085 38,450 168,535 0.08%
------------- ---------- ------------------ ---------- ------------
The Company further announces that it was notified on 26 June
2017 that Simon Coates, who is a Senior Manager and PDMR, following
the successful achievement of certain performance criteria, has
exercised 27,783 options from the Long Term Incentive Plan (LTIP).
Mr Coates has also exercised 7,888 Ordinary Shares of 5p from the
Deferred Share Bonus Plan (DSB). Mr Coates subsequently sold 17,448
Ordinary Shares of 5p each on 26 June 2017 at a share price of
301.8015p per Ordinary Share to cover the tax payable on these
exercises.
Following these transactions the beneficial ownership of Simon
Coates is as follows:
Long Term Incentive Plan (LTIP)
PDMR No. of LTIPs LTIPs exercised Ordinary LTIPs after
prior to shares exercise
exercise retained
-------------- ------------- ---------------- ---------- ------------
Simon Coates 101,409 27,783 10,335 73,626
-------------- ------------- ---------------- ---------- ------------
Deferred Share Bonus Plan (DSB)
PDMR No. of DSBs exercised Ordinary DSBs after
DSBs prior Shares exercise
to exercise sold
-------------- ------------- --------------- --------- -----------
Simon Coates 42,825 7,888 Nil 34,937
-------------- ------------- --------------- --------- -----------
Overall Holding
PDMR Holding Number of Number Sale Resultant % of issued
prior shares exercised of shares price holding share
to exercise sold (p) capital
--------- ------------- ------------------ ----------- ---------- ---------- ------------
Simon
Coates 73,481 35,671 17,448 301.8015p 91,704 0.04%
--------- ------------- ------------------ ----------- ---------- ---------- ------------
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial
responsibilities/person closely associated
--- --------------------------------------------------------
a) Name: Chris Meredith
--- --------------------------------------------------------
2. Reason for the notification
--- --------------------------------------------------------
a) Position/status: Director/PDMR
--- --------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- --------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- --------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- --------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- --------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- --------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- --------------------------------------------------------
b) Nature of the transactions:
* Exercise of 162,069 shares from the Long Term
Incentive Plan
* Sale of 76,604 Ordinary Shares of 5p
--- --------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
------------- ----------
GBP3.018015 76,604
------------- ----------
--- --------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: 76,604
Aggregated price: GBP3.018015
--- --------------------------------------------------------
e) Date of the transaction: 26/06/2017
--- --------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- --------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- --------------------------------------------------------
a) Name: Mary Tavener
--- --------------------------------------------------------
2. Reason for the notification
--- --------------------------------------------------------
a) Position/status: Director/PDMR
--- --------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- --------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- --------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- --------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- --------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- --------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- --------------------------------------------------------
b) Nature of the transactions:
* Exercise of 199,319 shares from the Long Term
Incentive Plan
* Sale of 148,423 Ordinary Shares of 5p
--- --------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
------------- ----------
GBP3.018015 54,519
------------- ----------
--- --------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: 54,519
Aggregated price: GBP3.018015
--- --------------------------------------------------------
e) Date of the transaction: 26/06/2017
--- --------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- --------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -------------------------------------------------------
a) Name: Jeff Willis
--- -------------------------------------------------------
2. Reason for the notification
--- -------------------------------------------------------
a) Position/status: Senior Manager/PDMR
--- -------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -------------------------------------------------------
b) Nature of the transaction:
* Exercise of 38,450 shares from the Long Term
Incentive Plan
--- -------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -------------------------------------------------------
e) Date of the transaction: 26/06/2017
--- -------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Simon Coates
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: Senior Manager/PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Exercise of 27,783 shares from the Long Term
Incentive Plan
* Exercise of 7,888 shares from the Deferred Share
Bonus Plan
* Sale of 17,448 Ordinary Shares of 5p
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
------------- ----------
GBP3.018015 17,448
------------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: 17,448
Aggregated price: GBP3.018015
--- -----------------------------------------------------------
e) Date of the transaction: 26/06/2017
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
-End -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Chief Financial
Officer
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Jonathan AMS@consilium-comms.com
Birt / Matthew Neal / Hendrik
Thys
Investec Bank plc(NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Daniel Adams / Patrick Robb
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical and advanced wound care markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
wound care products that include silver alginates, alginates,
foams, tissue adhesives, sutures and haemostats, which it sells
under white label as well as its own brand ActivHeal(R) , and
surgical tissue adhesives, sutures and haemostats, which markets
under its own brands; LiquiBand(R) and RESORBA(R) .
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 70 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Company has 600 employees. For more
information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFEFRLIAFID
(END) Dow Jones Newswires
June 29, 2017 08:53 ET (12:53 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024
